News

Lenabasum and the Endocannabinoid System Upcoming Phase lll Trial Results

Lenabasum-and-the-Endocannabinoid-System-Upcoming-Phase-lll-Trial-Results

Dr. Barbara White, Chief Medical Officer and Head of Research at Corbus Pharmaceuticals discusses Lenabasum, Corbus’ lead drug candidate that activates the often underutilized endocannabinoid system (ECS) to treat systemic sclerosis. Its Phase III trial recently completed treatment and is projected to release its data by the end of summer 2020.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Treatment?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Prior to joining Corbus, Dr. White was Senior Vice President and Head of R&D at Stiefel, a GSK company. Prior to her pharmaceutical career, Dr. White was Professor of Medicine and Vice-Chair for Research in the Department of Medicine at the University of Maryland School of Medicine. Her research has focused on T cells and immune-mediated mechanisms of lung fibrosis in scleroderma. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board-certified in internal medicine, rheumatology and allergy/clinical immunology.

 

Last updated: August 28, 2020

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.